Conflict of interest: Drs. Boyer and Haskal are paid consultants for W. L. Gore and Associates, Inc., the manufacturer of a polytetrafluoroethylene-covered stent used for TIPS.
The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension†
Article first published online: 19 JAN 2005
Copyright © 2005 American Association for the Study of Liver Diseases
Volume 41, Issue 2, pages 386–400, February 2005
How to Cite
Boyer, T. D. and Haskal, Z. J. (2005), The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension. Hepatology, 41: 386–400. doi: 10.1002/hep.20559
All AASLD Practice Guidelines are updated annually. If you are viewing a Practice Guideline that is more than 12 months old, please visit www.aasld.org for an update in the material.
- Issue published online: 19 JAN 2005
- Article first published online: 19 JAN 2005
- Manuscript Accepted: 18 NOV 2004
- Manuscript Received: 8 NOV 2004